Developing Countries

Subterms

    Latest story

    125 Shares35 Views

    COP29 Climate Talks in Baku, Azerbaijan, Head Into Final Stretch

    by

    Senior ministers are arriving in an effort to break a deadlock over the summit’s main goal: funding to help lower-income countries hit hard by global warming.More than halfway through the United Nations climate talks in Baku, Azerbaijan, negotiators from nearly 200 countries remain far apart on a number of the key issues up for debate.As nations try to agree on a plan to provide potentially trillions of dollars to developing countries suffering from the effects of climate change, divisions remain over how much money should be made available, what kind of financing efforts should count toward the overall goal and how recipient countries should gain access to the funds.Negotiations often go into overtime. But with just four days to go, many attendees fear that this could be the first summit since the Copenhagen talks in 2009 to conclude without a deal.“There is a high risk this could collapse,” said a senior negotiator for a major European country, who requested anonymity because they were not authorized to speak publicly.Simon Stiell, the United Nations climate chief, pleaded on Monday with countries to stop fighting and to reach a deal.He warned against a dynamic “where groups of parties dig in and refuse to move on one issue, until others move elsewhere.” He added, “This is a recipe for going literally nowhere.”We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

    More stories

    • 150 Shares32 Views

      in Elections

      A Loss and Damage Fund Is Taking Shape at COP Climate Talks

      by

      The U.N. climate summit in Azerbaijan has cleared the for way aid to flow when lower-income countries are hit.A long-awaited fund designed to help lower-income countries respond to natural disasters is finally taking shape at the U.N. climate conference in Baku, Azerbaijan.Wealthy nations agreed to create the fund at the 2022 climate summit in Sharm el Sheikh, Egypt, after decades of resistance. Last year, a group of nations, including the United States and the European Union, made the first financial commitments.Now, the fund has a leader and is looking to start distributing money within the next year.Ibrahima Cheikh Diong, who has Senegalese and American citizenship and has held roles at financial firms and at development banks, started this month as the inaugural executive director of the initiative, which is formally known as the Fund for Responding to Loss and Damage.At this year’s climate summit, known as COP29, formal agreements were signed that will allow the fund to begin formally receiving the money that has been pledged and to start distributing it soon. The fund is being managed by the United Nations, and the World Bank is serving as a financial trustee.Sweden this month became the latest country to make a pledge, with its $19 million contribution bringing total commitments to around $720 million.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

    • 163 Shares63 Views

      in Elections

      Nuclear Power Was Once Shunned at Climate Talks. Now, It’s a Rising Star.

      by

      Growing worldwide energy demand and other factors have shifted the calculus, but hurdles still lie ahead.For years at global climate summits, nuclear energy was seen by many as part of the problem, not part of the solution.Sama Bilbao y Leon has been attending the annual United Nations climate change talks since 1999, when she was a student of nuclear engineering. And for most of that time, she said, people didn’t want to discuss nuclear power at all.“We had antinuclear groups saying, ‘What are you doing here? Leave!’” she said.These days, it’s a very different story.At last year’s climate conference in the United Arab Emirates, 22 countries pledged, for the first time, to triple the world’s use of nuclear power by midcentury to help curb global warming. At this year’s summit in Azerbaijan, six more countries signed the pledge.“It’s a whole different dynamic today,” said Dr. Bilbao y Leon, who now leads the World Nuclear Association, an industry trade group. “A lot more people are open to talking about nuclear power as a solution.”The list of countries pledging to build new nuclear reactors, which can generate electricity without emitting any planet-warming greenhouse gases, includes longtime users of the technology like Canada, France, South Korea and the United States. But it also includes countries that don’t currently have any nuclear capacity, like Kenya, Mongolia and Nigeria.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

    • 138 Shares189 Views

      in Elections

      What to Know About the BRICS Summit and the Countries Involved

      by

      The group, which seeks to rebalance the global order away from the West, will meet on Tuesday. Here’s a primer.Leaders of BRICS, a group of emerging market nations that represent about half of the world’s population, will meet for a high-profile summit on Tuesday, their first since a major expansion last year.BRICS stands for Brazil, Russia, India, China and South Africa. This year, the group has expanded to include Egypt, Ethiopia, Iran and the United Arab Emirates. The members will gather for the three-day conference in Kazan, a city in southwest Russia.The summit comes at a high-profile moment for BRICS, which sees itself as a counterweight to the West. World leaders will stand side-by-side with President Vladimir V. Putin of Russia, despite his pariah status in the West.But there are deep differences between member states, and the bloc has struggled to articulate and define its purpose.Here’s what you need to know:What is BRICS?What holds the group together?What does the Global East want?What about the ‘Global South’?What does China want?Barbara Berasi for The New York TimesWe are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

    • 138 Shares99 Views

      in Elections

      Fears of a Global Oil Shock if the Mideast Crisis Intensifies

      by

      The threat of an escalating conflict between Israel and Iran has created an “extraordinarily precarious” global situation, sowing alarm about the potential economic fallout.As the world absorbs the prospect of an escalating conflict in the Middle East, the potential economic fallout is sowing increasing alarm. The worst fears center on a broadly debilitating development: a shock to the global oil supply.Such a result, actively contemplated in world capitals, could yield surging prices for gasoline, fuel and other products made with petroleum like plastics, chemicals and fertilizer. It could discourage investment, hiring, and business expansion, threatening many economies — particularly in Europe — with the risk of recession. The effects would be potent in nations that depend on imported oil, especially poor countries in Africa.The possibility of this calamitous outcome has come into focus in recent days as Israel plots its response to the barrage of missiles that Iran unleashed last week. Some scenarios are seen as highly unlikely, yet still conceivable: An Israeli strike on Iranian oil installations might prompt Iran to target refineries in Saudi Arabia or the United Arab Emirates, both major oil producers. Iranian-supported Houthi rebels claimed credit for an attack on Saudi oil installations in 2019. The Trump administration subsequently pinned the blame on Iranian forces.As it has done before, Iran might also threaten the passage of tankers through the Strait of Hormuz, the critical waterway that is the conduit for oil produced in the Persian Gulf, the source of nearly one-third of the world’s oil production. Such a move could entail conflict with American naval ships stationed in the region.That, too, is currently considered to be improbable. But the upheaval in the region in recent months has pushed out the parameters of possibility, rendering imaginable scenarios that were once dismissed as extreme.As Israel plots its next move, it has other targets besides Iranian oil installations. Iran would have reason for caution in crafting its own retaliation. Broadening the war to its Persian Gulf neighbors would invite a punishing response that could push Iran’s own economy — already bleak — to the brink of collapse.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

    • 163 Shares159 Views

      in Elections

      Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries

      by

      Many middle-income countries are left out of the deal, widening a gulf in access to critical medicines.The drugmaker Gilead Sciences on Wednesday announced a plan to allow six generic pharmaceutical companies in Asia and North Africa to make and sell at a lower price its groundbreaking drug lenacapavir, a twice-yearly injection that provides near-total protection from infection with H.I.V.Those companies will be permitted to sell the drug in 120 countries, including all the countries with the highest rates of H.I.V., which are in sub-Saharan Africa. Gilead will not charge the generic drugmakers for the licenses.Gilead says the deal, made just weeks after clinical trial results showed how well the drug works, will provide rapid and broad access to a medication that has the potential to end the decades-long H.I.V. pandemic.But the deal leaves out most middle- and high-income countries — including Brazil, Colombia, Mexico, China and Russia — that together account for about 20 percent of new H.I.V. infections. Gilead will sell its version of the drug in those countries at higher prices. The omission reflects a widening gulf in health care access that is increasingly isolating the people in the middle.Gilead charges $42,250 per patient per year for lenacapavir in the United States, where it is approved as a treatment for H.I.V. The company has said nothing about what lenacapavir will cost when used to prevent H.I.V. infections, a process called pre-exposure prophylaxis, or PrEP.The generics makers — four companies in India, one in Pakistan and one in Egypt — are expected to sell it for much less. Researchers at Liverpool University found the drug could profitably be produced for as little as $40 per patient per year, if it were being purchased in large volumes.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

    • 125 Shares189 Views

      in Elections

      W.H.O. Authorizes Mpox Vaccine, Clearing Way for Use in Africa

      by

      The decision is a crucial step in getting shots to the Democratic Republic of Congo, the center of the outbreak.The World Health Organization has given its authorization to a first vaccine to protect against mpox, a decision announced in such haste on Friday that it caught even the head of the company that makes the vaccine by surprise.The vaccine, made by the Danish company Bavarian Nordic, has been approved by the regulatory authorities in Europe as well as the United States and other high-income countries since a global mpox outbreak in 2022. But low- and middle-income countries rely on the W.H.O., through a process called prequalification, to determine which drugs, vaccines and health technologies are safe and efficient uses of limited health funding, and the organization had declined to act until now.The W.H.O. had come under increasing criticism for declaring a global public health emergency for mpox last month without giving a vaccine that prequalification stamp of approval, or a more provisional form of approval called emergency use authorization. Bavarian Nordic first submitted its safety and effectiveness data on the vaccine, called Jynneos, to the W.H.O. in 2023. The W.H.O. had defended its slow pace of review, saying that it needed to subject the vaccine to careful study because it, and two others that have been used to protect against mpox, were originally designed as smallpox immunizations, and because delivering it in low-resource settings such as Central Africa would involve factors different from those relating to its use in high-income countries.But on Friday morning, the W.H.O. suddenly said it was authorizing the shot.“This first prequalification of a vaccine against mpox is an important step in our fight against the disease, both in the context of the current outbreaks in Africa, and in future,” Dr. Tedros Adhanom Ghebreyesus, the W.H.O. director general, said in a statement.Paul Chaplin, Bavarian Nordic’s chief executive, said he was among the many who had been caught off guard.“We’ve got there eventually — I don’t know quite how,” he said. “But it’s good news. It’s going to make the regulatory pathway much easier.”We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

    • 113 Shares189 Views

      in Elections

      China Woos Africa, Casting Itself as Global South’s Defender

      by

      More than 50 African leaders have gathered in Beijing for a summit aimed at projecting the influence of China’s leader, Xi Jinping, in the developing world.African flags have been flown over Tiananmen Square. Leaders of African nations have been greeted by dancers, honor guards and children waving flags. They have been escorted in extensive motorcades past banners celebrating “A Shared Future for China and Africa” and giant, elaborate flower arrangements.China has pulled out all the stops for a gathering of leaders and top officials from more than 50 African nations this week in Beijing, welcoming them with pomp and pageantry. “After nearly 70 years of hard work, China-Africa relations are at the best period in history,” China’s leader, Xi Jinping, told the gathering on Thursday. Mr. Xi has cast his country as a defender of the developing world, one that can push the West to listen to the voices of poorer countries. He hosted a banquet for the leaders at the start of the event on Wednesday, after three straight days of back-to-back bilateral talks with nearly two dozen leaders of nations ranging from impoverished Chad to the continental economic powerhouse of Nigeria. The three-day forum is meant to demonstrate Beijing’s global clout despite rising tensions with the West. Mr. Xi’s courtship of African countries is part of a great geopolitical competition with the United States that has intensified in recent years over Russia’s war in Ukraine and China’s aggressive posture toward Taiwan.China is “trying to take advantage of the space left by the U.S. and Europe, which are increasingly disengaged with Africa,” said Eric Olander, the editor in chief of the China-Global South Project website. “China sees an opportunity to really step up its engagement, and not necessarily just with money.”We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

    • 163 Shares199 Views

      in Elections

      Gilead Shot Provides Total Protection From HIV in Trial of Young African Women

      by

      An injection given just twice a year could herald a breakthrough in protecting the population that has the highest infection rates.Researchers and activists in the trenches of the long fight against H.I.V. got a rare piece of exciting news this week: Results from a large clinical trial in Africa showed that a twice-yearly injection of a new antiviral drug gave young women total protection from the virus.“I got cold shivers,” said Dr. Linda-Gail Bekker, an investigator in the trial of the drug, lenacapavir, describing the startling sight of a line of zeros in the data column for new infections. “After all our years of sadness, particularly over vaccines, this truly is surreal.”Yvette Raphael, the leader of a group called Advocacy for Prevention of H.I.V. and AIDS in South Africa, said it was “the best news ever.”The randomized controlled trial, called Purpose 1, was conducted in Uganda and South Africa. It tested whether the every-six-months injection of lenacapavir, made by Gilead Sciences, would provide better protection against H.I.V. infection than two other drugs in wide use in high-income countries, both daily pills.The results were so convincing that the trial was halted early at the recommendation of the independent data review committee, which said all participants should be offered the injection because it clearly provided superior protection against the virus.None of the 2,134 women in the arm of the trial who received lenacapavir contracted H.I.V. By comparison, 16 of the 1,068 women (or 1.5 percent) who took Truvada, a daily pill that has been available for more than a decade, and 39 of 2,136 women (1.8 percent) who received a newer daily pill called Descovy were infected.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More